Benoit CHARDON

Benoît is a global leader in medical aesthetics with a rare dual track record: category-creating innovation and large-scale value creation.

Corporate Value Creation

• Filorga – Created the brand and led skincare development; later acquired by Colgate-Palmolive for $1.4bn

• CoolSculpting – Led international marketing; category-defining body contouring platform acquired by Allergan for $2.5bn

• Allurion – Scaled revenue as CCO from $3m to $65m, leading to a $0.5bn NYSE IPO

• Fastox – Board Member; contributed to acquisition by AbbVie

Innovation That Changed the Market

• Restylane Skinboosters (15 years ago): shifted injectables from volume to skin quality, creating an entirely new treatment category

• Sculptra Relaunch (10 years ago): repositioned biostimulation as a long-term regenerative strategy, redefining collagen-based aesthetics

Most recently, Benoît has been appointed to the IMCAS Industry Innovation Jury, as the main award of the IMCAS Innovation Tank and as Chairman of the AMWC Catalyst, reinforcing his position as a leading authority on disruptive innovation in medical aesthetics.